Impact of colonization with multidrug-resistant bacteria on the risk of ventilator-associated pneumonia in septic shock.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
10 2022
Historique:
received: 02 02 2022
revised: 09 05 2022
accepted: 11 05 2022
pubmed: 1 6 2022
medline: 3 9 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

The objective is to identify the risk markers of multi-drug resistant bacteria (MDRB) related ventilator-associated pneumonia (VAP) in septic shock patients with previous MDRB carriage. This retrospective study was conducted in a medical ICU from 2010 to 2020. Consecutive patients with septic shock and still in the ICU after 48 h, were eligible. The following microorganisms were defined as MDRB: extended-spectrum beta-lactamase producing enterobacteriaceae, methicillin-resistant Staphylococcus aureus, multi-drug resistant Pseudomonas aeruginosa, imipenem-resistant Acinetobacter baumanii and Stenotrophomonas maltophilia. Screening for MDRB colonization was performed at ICU admission and during ICU stay. The determinants of MDRB-related VAP were assessed using a time-dependent cause-specific Cox model. 643 patients were analyzed and 122 (18.9%) had at least one episode of VAP. The overall ICU mortality was 32.5%. The incidence of MDRB carriage was 31%, distributed into MDRB carriage at admission (14.3%) and MDRB acquired during ICU stay (16.7%). In multivariate analysis, MDRB colonization in ICU was independently associated with an increased risk of VAP (CSH: 1.85; 95% CI: 1.05-3.23; p = 0.03) whereas carriage prior to admission was not. Imported and acquired MDRB carriage harbor different risks of subsequent MDRB-related VAP in patients with septic shock.

Identifiants

pubmed: 35636346
pii: S0883-9441(22)00097-1
doi: 10.1016/j.jcrc.2022.154068
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154068

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Swann Bredin (S)

Service de médecine intensive réanimation, hôpital Cochin, AP-HP. CUP, Paris, France; Université de Paris, Paris, France. Electronic address: swann.bredin@aphp.fr.

Julien Charpentier (J)

Service de médecine intensive réanimation, hôpital Cochin, AP-HP. CUP, Paris, France.

Jean-Paul Mira (JP)

Service de médecine intensive réanimation, hôpital Cochin, AP-HP. CUP, Paris, France; Université de Paris, Paris, France; Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France.

Nabil Gastli (N)

Laboratoire de bactériologie, hôpital Cochin, AP-HP. CUP, Paris, France.

Frédéric Pène (F)

Service de médecine intensive réanimation, hôpital Cochin, AP-HP. CUP, Paris, France; Université de Paris, Paris, France; Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France.

Jean-François Llitjos (JF)

Service de médecine intensive réanimation, hôpital Cochin, AP-HP. CUP, Paris, France; Université de Paris, Paris, France; Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH